Chelsea Lazkani's Health Battle: Inside Her Adenomyosis Diagnosis & Advocacy

Chelsea Lazkani reveals her adenomyosis diagnosis. Learn the symptoms, treatments, & her powerful advocacy for women's health awareness & better care.

Chelsea Lazkani's Health Battle: Inside Her Adenomyosis Diagnosis & Advocacy

Away from the glossy world of Selling Sunset, Chelsea Lazkani is stepping into a far more personal spotlight—one defined by honesty, vulnerability, and resilience. In recent interviews, Lazkani confirmed that she has been diagnosed with adenomyosis, a painful and often overlooked gynecological condition. The disorder occurs when tissue similar to the uterine lining grows into the uterus’s muscular wall, frequently causing severe cramping, heavy periods, and ongoing fatigue. By speaking openly, Lazkani is helping bring visibility to a condition that affects millions but is still widely misunderstood.

For Chelsea, this journey is about more than receiving a medical label—it’s about being heard. “I was in excruciating pain… I knew something wasn’t right,” she shared, a sentiment that resonates with countless women whose symptoms are minimized or dismissed. Her message is clear and deeply personal: listen to your body, and don’t stop advocating for yourself. “I want to use my voice for all the women who go unheard,” Lazkani said, turning her own struggle into a call for better care, deeper listening, and greater trust in women’s lived experiences.

Although Lazkani is known for prioritizing wellness and maintaining a healthy lifestyle, adenomyosis underscores an important medical reality: this condition isn’t caused by poor habits or neglect. Its exact origins are still being studied. What doctors do know is that adenomyosis is estrogen-dependent, commonly diagnosed between ages 40 and 50, and can exist alongside conditions such as endometriosis. Research published in the Journal of Clinical Medicine highlights its significant impact on quality of life, while the Office on Women’s Health recognizes it as both common and frequently underdiagnosed—leaving many patients searching for answers for years, as Chelsea did.

Treatment for adenomyosis depends on symptom severity and personal factors like future family plans. Options range from pain management and hormonal therapies—such as birth control or hormonal IUDs—to surgical interventions, including hysterectomy in severe cases. The American College of Obstetricians and Gynecologists (ACOG) notes that many patients do find meaningful relief, though treatment often involves trial and adjustment. Side effects, emotional strain, and difficult decisions are common along the way. While adenomyosis is chronic, appropriate care can significantly reduce pain and improve daily life.

Chelsea has spoken openly about the role her husband, Jeff, and their two children play in helping her through this chapter, highlighting how chronic illness affects not just the patient but the entire family. Her story also sheds light on a broader healthcare divide. While she has access to top specialists and advanced treatment options, many Americans with adenomyosis face long wait times, limited insurance coverage, and overwhelming medical costs. In sharing her experience, Lazkani brings awareness not only to the condition itself, but also to the unequal access to care that continues to define women’s health in the U.S.

Chelsea Lazkani’s most meaningful message isn’t about luxury real estate—it’s about the urgent need to believe women’s pain, invest in their health, and make quality care accessible to everyone.